Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging

Bhat, Asif Ahmad; Moglad, Ehssan; Goyal, Ahsas; Afzal, Muhammad; Thapa, Riya; Almalki, Waleed Hassan; Kazmi, Imran; Alzarea, Sami I.; Ali, Haider; Gaur, Ashish; Singh, Thakur Gurjeet; Singh, Sachin Kumar; Dua, Kamal; Gupta, Gaurav

doi:10.1016/j.lfs.2024.123056

Life Sciences

2024

DOI: 10.1016/j.lfs.2024.123056

|View full text |Cite

Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging

Asif Ahmad Bhat,

Ehssan Moglad,

Ahsas Goyal

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 206 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Role of NRF2 in Pathogenesis of Alzheimer’s Disease

Chu,

Uruno,

Katsuoka

et al. 2024

Antioxidants

View full text Add to dashboard Cite

Alzheimer’s disease (AD) is a polygenic, multifactorial neurodegenerative disorder and remains the most prevalent form of dementia, globally. Despite decades of research efforts, there is still no effective cure for this debilitating condition. AD research has increasingly focused on transcription factor NRF2 (nuclear factor erythroid 2-related factor 2) as a potential therapeutic target. NRF2 plays a crucial role in protecting cells and tissues from environmental stressors, such as electrophiles and reactive oxygen species. Recently, an increasing number of studies have demonstrated that NRF2 is a key regulator in AD pathology. NRF2 is highly expressed in microglia, resident macrophages in the central nervous system, and contributes to neuroinflammation, phagocytosis and neurodegeneration in AD. NRF2 has been reported to modulate microglia-induced inflammation and facilitate the transition from homeostatic microglia to a disease-associated microglia subset. Genetic and pharmacological activation of NRF2 has been demonstrated to improve cognitive function. Here, we review the current understanding of the involvement of NRF2 in AD and the critical role that NRF2 plays in microglia in the context of AD. Our aim is to highlight the potential of targeting NRF2 in the microglia as a promising therapeutic strategy for mitigating the progression of AD.

show abstract

Role of NRF2 in Pathogenesis of Alzheimer’s Disease

Chu,

Uruno,

Katsuoka

et al. 2024

Antioxidants

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging

Cited by 1 publication

References 206 publications

Role of NRF2 in Pathogenesis of Alzheimer’s Disease

Role of NRF2 in Pathogenesis of Alzheimer’s Disease

Contact Info

Product

Resources

About